OR
MRNA icon

Olympiad Research’s Moderna MRNA Stock Holding History

Olympiad Research’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$503K Hold
4,256
– – 0.27% 90
2022
Q2 		$608K Buy
4,256
+217
+5% +$31K 0.27% 103
2022
Q1 		$696K Hold
4,039
– – 0.21% 116
2021
Q4 		$1.03M Buy
4,039
+1,346
+50% +$394K 0.37% 78
2021
Q3 		$1.04M Hold
2,693
– – 0.32% 101
2021
Q2 		$633K Hold
2,693
– – 0.22% 117
2021
Q1 		$353K Hold
2,693
– – 0.15% 135
2020
Q4 		$281K Buy
+2,693
New +$272K 0.16% 100

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Olympiad Research's MRNA Position: Q3 2022 in Review

Olympiad Research held its Moderna (MRNA) position steady in Q3 2022 at 4,256 shares worth $503K. The position accounts for 0.27% of the portfolio, ranked #90.

Olympiad Research first reported a position in MRNA in Q4 2020 and has held it in 8 quarters since. The position peaked at $1.04M in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Olympiad Research held 4,256 shares of Moderna worth $503K as of Q3 2022.
  • Olympiad Research left its Moderna share count unchanged in Q3 2022.
  • Moderna made up 0.27% of Olympiad Research's portfolio in Q3 2022, its #90 holding.
  • Olympiad Research first reported a position in Moderna in Q4 2020 and has held it in 8 quarters since.
  • Olympiad Research's Moderna position peaked at $1.04M in Q3 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Olympiad Research's 13F filing for Q3 2022, filed 7 Nov 2022.